A review of a paediatric emergency department vaccination programme for patients at risk of allergy/anaphylaxis

Acta Paediatr. 2012 Sep;101(9):941-5. doi: 10.1111/j.1651-2227.2012.02737.x. Epub 2012 Jun 12.

Abstract

Aim: We sought to review the clinical outcomes of patients referred to our emergency department (ED) vaccination service for children with a history of allergy or anaphylaxis or in whom there was a concern of a significant adverse reaction.

Methods: This was a prospective observational cohort study set in an urban tertiary Paediatric ED. All attendances for any childhood vaccination for a 5-year period (from January 1, 2006 to December 31, 2010) were included. Our primary outcome measure was any adverse reaction as a result of the vaccine administered.

Results: A total of 446 vaccines were administered during the study period in 374 patients. Of these vaccinations, 310 (69.5%) were Measles, Mumps, Rubella (MMR). The majority of patients (348, 93%) were referred from the community. Suspected egg allergy was the reason for the majority of referrals for MMR (261/310 (84.2%)). Only six patients (1.3%) experienced an immediate reaction to a vaccination. All reactions were minor.

Conclusion: This is one of the largest studies looking at childhood vaccinations performed in a hospital setting for children who are 'at risk' of allergy, anaphylaxis or hypersensitivity. A significant number of referrals were unwarranted and the majority could have been safely managed in the community.

MeSH terms

  • Anaphylaxis / epidemiology
  • Child
  • Child, Preschool
  • Emergency Service, Hospital
  • Female
  • Humans
  • Hypersensitivity / epidemiology
  • Infant
  • Male
  • Measles-Mumps-Rubella Vaccine
  • Prospective Studies
  • Referral and Consultation
  • Risk Assessment
  • Vaccination* / adverse effects

Substances

  • Measles-Mumps-Rubella Vaccine